In addition, a high expression of BCL-w rendered resistance of ovarian cancer cells to cisplatin, and BCL-w knockdown significantly reduced size of tumor derived from cisplatin-resistant cells127. This evidence concerns the gene BCL2L2 and ovarian carcinoma.